Related Experiment Video

Updated: Jun 7, 2025

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.2K

Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review

Alisha Lakhani1,2, Ruchira Clementina3, Zainab Siddiqua4

  • 1Research, Research MD, Vadodara, IND.

Cureus
|November 20, 2024
PubMed

Insights

This review compares cystic fibrosis (CF) treatments for children, evaluating medications, airway clearance, nutrition, and new therapies like gene therapy. It emphasizes personalized care plans to improve outcomes for pediatric CF patients.

Area of Science:

  • Pediatric Pulmonology
  • Genetic Disorders
  • Medical Therapeutics

Background:

  • Cystic Fibrosis (CF) is a genetic disorder impacting pediatric respiratory and digestive systems.
  • Effective management of CF in children requires a multifaceted approach.
  • Current treatment landscape necessitates comparative analysis for optimized care.

Purpose of the Study:

  • To comparatively analyze diverse treatment modalities for pediatric cystic fibrosis.
  • To evaluate the efficacy, safety, and accessibility of current and emerging CF therapies.
  • To identify factors influencing treatment outcomes in pediatric CF patients.

Main Methods:

  • Systematic literature review of pharmacological interventions, airway clearance techniques, and nutritional management.
  • Comparative analysis of CF transmembrane conductance regulator (CFTR) modulators versus traditional treatments.
  • Inclusion of emerging therapies such as gene therapy and personalized medicine.

Main Results:

  • Efficacy and safety profiles of various CF treatments were compared across diverse pediatric populations.
  • Airway clearance techniques' effectiveness was linked to lung function outcomes.
  • Socioeconomic factors and healthcare systems influence treatment adherence and outcomes.

Conclusions:

  • Individualized care plans are crucial for optimizing pediatric CF patient outcomes.
  • Comparative analysis provides a foundation for refining therapeutic strategies.
  • Further research into emerging therapies and personalized medicine is warranted.

Keywords:
cf diagnosiscftr mutationcystic fibrosis (cf)general pediatricspharmacologic management

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

475
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

10.6K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
142
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123